Researchers have developed a method to engineer sugar clusters attached to proteins or lipids, called glycan complexes, to target particular organs of the body. A team from the Riken Biofunctional Synthetic Chemistry Laboratory in Japan and Kazan Federal University in Russia published their work in Advanced Science.
The engineered sugar clusters could lead to glycocluster-based diagnostic tools with improved selectivity and precision compared to peptide or antibody-based tracers, according to the group.
Get the full story at our sister site, Drug Delivery Business News.
The post Engineered sugar clusters could enable targeted drug delivery appeared first on MassDevice.
from MassDevice http://ift.tt/2fF71SN
Cap comentari:
Publica un comentari a l'entrada